Jeremy brings extensive financial and pharmaceutical industry experience to DCVC Bio. Jeremy served in senior strategy and investment roles at Genentech and GE Healthcare Ventures. He was an Equity Research Analyst covering the US pharmaceutical, life sciences and medical diagnostic industries for Credit Suisse. Jeremy also worked in investment banking roles at Lazard, Morgan Stanley and Credit Suisse. Jeremy received a BS in Bioengineering from Rice University, a MS in Bioengineering from the University of Washington School of Medicine and a MBA from Stanford Graduate School of Business, where he was a Sloan Fellow.